Keyphrases
Activity in Vivo
12%
Acyclovir
100%
Acyclovir Resistance
100%
Adjusted Odds Ratio
25%
Anti-cytomegalovirus Activity
12%
Anti-herpes Simplex Virus
6%
Antibody Production
11%
Breastfeeding Initiation
6%
Cell-free Virus
25%
Childrens
37%
CMV Infection
12%
Confidence Interval
8%
Cross-resistance
25%
Cyclosporine
15%
Cytomegalovirus Disease
6%
Cytomegalovirus Infection
50%
Disinfection Efficiency
25%
During Pregnancy
5%
Early Pregnancy
8%
Early Skin-to-skin Contact
6%
Episodic Treatment
6%
Exclusive Breastfeeding
25%
Exclusively Breastfed
6%
FK506
25%
Ganciclovir
6%
Genital Herpes
10%
Genital Lesions
10%
Geum Japonicum
18%
Glycoprotein
25%
Guanosine
25%
Herbal Extracts
6%
Herpes Simplex Virus
51%
Herpes Simplex Virus 2 (HSV-2)
40%
Herpes Simplex Virus Type 1 (HSV-1)
6%
History of Miscarriage
7%
Hot Water Extract
6%
Human Cytomegalovirus
12%
Immunocompromised Patients
6%
Immunodeficient Mice
6%
Immunosuppression
11%
In Vitro Activity
6%
Infected Mice
14%
Infection Model
6%
Inhibitory Action
25%
Inhibitory Activity
12%
Intraperitoneal Administration
6%
Intraperitoneal Infection
6%
Japan
64%
Late Pregnancy
7%
Lung
27%
Miscarriage
12%
Monoclonal Antibody
12%
Murine CMV
18%
Natural Killer Cell Activity
25%
Nave
8%
Neuraminidase
25%
Oral Treatment
6%
Orally Administered
6%
Penciclovir
25%
Plaque
6%
Plaque Formation
40%
Plaque-forming Units
10%
Post-infection
27%
Pregnant Women
12%
Production Yield
6%
Prophylactic Treatment
25%
Quality of Life
12%
Resistant Clones
8%
Resistant Virus
31%
Rhus Javanica
6%
Rooming-in
6%
Stillbirth
12%
Suppressive Therapy
35%
Syzygium Aromaticum
12%
Terminalia Chebula
12%
Thymidine Kinase
5%
Traditional Herbs
25%
Varicella Zoster Virus
37%
Varicella-zoster Virus Infection
25%
Viral
14%
Viral Glycoprotein
12%
Virus
14%
Virus Activity
6%
Virus Infection
25%
Virus Isolate
27%
Virus Population
6%
Virus Yield
18%
Water Treatment
6%
Immunology and Microbiology
Antibody Production
5%
Antiviral Activity
5%
Cross-Resistance
25%
Cytomegalovirus Infection
25%
Defective Interfering Particle
12%
DNA Polymerase
10%
DNA Virus
5%
EC50
5%
Effective Concentration
10%
First Trimester Pregnancy
9%
Genital Herpes
45%
Glycoprotein
25%
Herpes Simplex Virus
62%
Herpes Simplex Virus 2
66%
Human Alphaherpesvirus 1
25%
IC50
8%
Immunosuppression
5%
Low Drug Dose
25%
Monoclonal Antibody
8%
Natural Killer Cell
25%
Plaque-Forming Unit
41%
Tacrolimus
25%
Third Trimester Pregnancy
12%
Varicella Zoster Virus
50%
Viral Disease
25%
Viral Entry
8%
Virus Resistance
5%
Virus Strain
5%
Virus Type
12%
Pharmacology, Toxicology and Pharmaceutical Science
Aciclovir
50%
Ciclosporin
12%
Clove
12%
Cross-Resistance
25%
Cytomegalovirus
12%
Cytomegalovirus Infection
25%
Ganciclovir
6%
Geum
18%
Glycoprotein
25%
Guanosine
25%
Herpes Simplex Virus
31%
Herpes Zoster
25%
Hot Water
6%
Human Cytomegalovirus
6%
Immunocompromised Patient
6%
Infection
27%
Monoclonal Antibody
12%
Murine Cytomegalovirus
6%
Penciclovir
25%
Peritonitis
6%
Rhus
6%
Sialidase
25%
Terminalia chebula
12%
Varicella Zoster Virus
37%
Virus Glycoprotein
12%
Virus Infection
25%